Patient Perspective: A conversation with Elja van der Veer – Former IMP Chair

find more articles

Clarifying the Phenotypic Spectrum of m.3243A>G: A Proposal for Terminological Precision in PMD

Khondrion Secures up to €5 Million Innovation Credit from Dutch Government plus Additional Funding from Current Investors to Advance Phase 3 Clinical Trial in m.3243A>G Primary Mitochondrial Disease

UMDF and Khondrion Announce The Mito Fund’s Investment in Khondrion to Support Development of One of the Most Advanced Drug Candidates for Primary Mitochondrial Disease

view all articles